RESMED/IDR UNRESTR (ASX:RMD) Share Price Crosses Below Two Hundred Day Moving Average of $16.15

RESMED/IDR UNRESTR (ASX:RMD)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $16.15 and traded as low as $19.40. RESMED/IDR UNRESTR shares last traded at $19.41, with a volume of 971,733 shares changing hands.

The company has a quick ratio of 1.23, a current ratio of 2.06 and a debt-to-equity ratio of 61.33. The business has a fifty day simple moving average of A$18.77 and a 200 day simple moving average of A$16.15. The company has a market cap of $27.83 billion and a price-to-earnings ratio of 69.32.

The firm also recently announced a Final dividend, which will be paid on Thursday, September 19th. Shareholders of record on Thursday, September 19th will be issued a $0.039 dividend. This represents a yield of 0.21%. The ex-dividend date of this dividend is Wednesday, August 14th. RESMED/IDR UNRESTR’s dividend payout ratio (DPR) is currently 82.14%.

RESMED/IDR UNRESTR Company Profile (ASX:RMD)

ResMed Inc develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.

Further Reading: How can investors benefit from after-hours trading?

Receive News & Ratings for RESMED/IDR UNRESTR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RESMED/IDR UNRESTR and related companies with MarketBeat.com's FREE daily email newsletter.